Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Estrogen receptor-a disruption and vasodilation in coronary arteries

13.11.2003


In women, the risk of coronary heart disease increases significantly after menopause. Estrogen therapy, however, reduces the risk of cardiovascular disease in healthy postmenopausal women. Estrogen enhances endothelial function of the coronary arteries, and this may contribute to the cardioprotective effects of the female hormone.



The precise mechanisms that mediate the beneficial effects of estrogen on arterial endothelial function are incompletely understood. What is known is that the long-term effects of estrogen occur through activation of estrogen receptors and subsequent modulation of gene expression. Moreover, estrogen has also been shown to effect endothelium-dependent function via its effects on expression of endothelial nitric oxide synthase.

A New Study


Accordingly, a new study tests the hypothesis that estrogen modulates nitric oxide (NO)-dependent vasodilation of coronary arteries through its action on estrogen receptor-á (ER-á) to increase protein levels of endothelial nitric oxide synthase (eNOS) and Cu/Zn superoxide dismutase (SOD-1). The authors of the study, entitled “Regulation of Nitric Oxide-Dependent Vasodilatation in Coronary Arteries of Estrogen Receptor-á-Deficient Mice,” are Judy M. Muller-Delp, Kathryn E. Nichol, Texas A&M University, College Station, TX; and Dennis B. Lubahn, Brian J. Philips, Elmer M. Price, Edward M. Curran and M. Harold Laughlin, all of the University of Missouri, Columbia, MO. Their findings appear in the November 2003 edition of the American Journal of Physiology—Heart and Circulatory Physiology, one of 14 journals published each month by the American Physiological Society (APS).

Methodology

The investigators followed the primary procedures outlined below:

Animals: A total of 43 ERá knockout (ERáKO) mice and 36 wild-type (WT) female mice were used for the study of coronary artery vasomotor reactivity experiments. A total of 19 ERáKO and 18 WT females were used for immunoblot experiments. The average age of ERáKO mice was 16 + 1 wk. In WT mice, the average age was 15 + 1 wk. Within the WT group, 16 mice were ovariectomized. Sixteen ERáKO mice were ovariectomized. Experiments were performed beginning 10 days or more after ovariectomy. Estrogen treatment was initiated after 10 days of rest following the procedure. Seventeen of the ovariectomized ERáKO and eight of the ovariectomized WT mice received subcutaneous implants of a 17â-estradiol (E2) pellet; E2 treatment was continued for 14 days before the mice died and the coronary arteries were harvested.

Isolation of coronary arteries: The hearts were excised and placed in cold saline solution. With the use of a dissecting microscope, coronary arteries were dissected free of surrounding myocardium and cannulated. Arteries that exhibited leaks were discarded and the remainder pressurized. Spontaneous tone was ensured between the WT and ERáKO mice.

Evaluation of eNOS and SOD-1 protein: Coronary arteries were isolated from the myocardium, as noted above, and frozen in microcentrifuge tubes. Because there was insufficient protein in a single mouse coronary artery to allow measurement of protein content and still have sufficient sample to run on an SDS gel, it was necessary to pool samples of coronary arteries from three mice into one sample. The eNOS and SOD-1 protein content was determined by loading equal amounts of total artery protein from equal numbers of different groups on the same gel, allowing comparisons between groups on the same gel.

Solutions and drugs: Stock solutions of albumin and endothelin were used.

Data analysis: Tone development was expressed as the percent decrease from maximal diameter according to the formula: Tone (%) = [(Dm – D8)/Dm] x 100, where Dm is the maximal diameter recorded at 60 cmH2O and Ds is the steady-state diameter recorded after equilibration of the vessel. Vasodilatory responses were recorded as actual diameters and subsequently expressed as the percent of maximal relaxation, according to the formula Relaxation (%) = [(D8 – Db)/Dm – Db)] x 100, where Ds is recorded after each addition of the drug and Db is the initial baseline diameter recorded immediately before the first addition of the vasodilatory agent. A two-way repeated-measures ANOVA was used to detect differences between and within factors. Statistical significance was defined as P < 0.05.

Results

The primary findings of this study reveal that:
  • NO-mediated vasodilation was preserved in coronary arteries from ERáKO mice;

  • SOD-1 protein content increased in coronary arteries from ERáKO mice;

  • ovariectomy reduced NO-mediated vasodilation and protein levels for eNOS and SOD-1 in ERáKO mice; and

  • E2 supplementation restored NO-mediated vasodilation and protein content of eNOS and SOD-1 in ovariectomized ERáKO mice.

Conclusions and Discussion

Based on the above findings, the researchers conclude that NO-mediated dilation is preserved in ERáKO mice through compensatory activation of ER-á independent pathways. Further study is needed to determine whether modulation of endothelium-dependent, NO-mediated vasodilation in coronary arteries occurs through an ER-â pathway.


Source: November 2003 edition of the American Journal of Physiology—Heart and Circulatory Physiology.

Donna Krupa | APS
Further information:
http://www.the-aps.org/press/journal/21.htm

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>